Back to results
US 12,630,613 B2Granted
Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
AssigneeTakeda Pharmaceutical Company Limited
InventorsWolfgang Teschner, Harald Arno Butterweck, Azra Pljevljakovic, Theresa Friederike Bauer, Bernhard Koelbl, Hans-Peter Schwarz, Nebojsa Nikolic, Gerhard Poelsler, Johanna Kindermann
Life of this patent
Estimating the term…
Abstract
The present invention relates to a new and improved method for preparing a highly concentrated immunoglobulin composition from pooled plasma for subcutaneous injection. A composition comprising 20% or more immunoglobulin suitable for subcutaneous use is also described.
Claims19
A method for preparing a composition of concentrated IgG from plasma, comprising:
- a) precipitating a cryo-poor plasma fraction, in a first precipitation step, with about 8% alcohol (v/v) at a pH of from 7.0 to 7.5 to obtain a first precipitate and a first supernatant;
- b) precipitating IgG from the first supernatant, in a second precipitation step, with from 20% to 25% alcohol (v/v) at a pH of from 6.8 to 7.2 to form a second precipitate and a second supernatant;
- c) suspending the second precipitate to form a suspension;
- d) adding fumed silica to the suspension and mixing the fumed silica with the suspension;
- e) filtering the suspension after the mixing in step d) to form a third supernatant containing IgG;
- f) further purifying IgG from the third supernatant to form an enriched IgG composition, wherein the further purifying comprises ion exchange chromatography;
- g) concentrating the enriched IgG composition to a protein concentration of from 2% to 10% (w/v) to form a first ultrafiltrate;
- h) diafiltering the first ultrafiltrate against a formulation buffer to form a diafiltrate;
- and
- i) concentrating the diafiltrate to a protein concentration of at least 20%, thereby preparing a composition of concentrated IgG from plasma.
7 more elements
Dependencies are inferred from the claim text.